Klass A et al. |
d-Cycloserine facilitates extinction learning and enhances extinction-related brain activation. |
2017 |
Neurobiol Learn Mem |
pmid:28807795
|
Malan-Müller S et al. |
The role of microRNAs in the therapeutic action of D-cycloserine in a post-traumatic stress disorder animal model: an exploratory study. |
2017 |
Psychiatr. Genet. |
pmid:28574862
|
Forsyth JK et al. |
Effects of Augmenting N-Methyl-D-Aspartate Receptor Signaling on Working Memory and Experience-Dependent Plasticity in Schizophrenia: An Exploratory Study Using Acute d-cycloserine. |
2017 |
Schizophr Bull |
pmid:28338977
|
Olden M et al. |
Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD. |
2017 |
J. Nerv. Ment. Dis. |
pmid:27441461
|
Kim SW et al. |
Low-Dose d-Cycloserine for Depression? |
2016 |
J Clin Psychiatry |
pmid:27561144
|
Hofmann SG |
Schrödinger's Cat and d-Cycloserine to Augment Exposure Therapy-Both Are Alive and Dead. |
2016 |
JAMA Psychiatry |
pmid:27367470
|
Kantrowitz JT et al. |
d-Cycloserine, an NMDA Glutamate Receptor Glycine Site Partial Agonist, Induces Acute Increases in Brain Glutamate Plus Glutamine and GABA Comparable to Ketamine. |
2016 |
Am J Psychiatry |
pmid:27903101
|
Schnitzer TJ et al. |
A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain. |
2016 |
Mol Pain |
pmid:27852965
|
Kapolowicz MR and Thompson LT |
Acute high-intensity noise induces rapid Arc protein expression but fails to rapidly change GAD expression in amygdala and hippocampus of rats: Effects of treatment with D-cycloserine. |
2016 |
Hear. Res. |
pmid:27702572
|
Eniyan K et al. |
Development of a one-pot assay for screening and identification of Mur pathway inhibitors in Mycobacterium tuberculosis. |
2016 |
Sci Rep |
pmid:27734910
|
Günthner J et al. |
The NMDA receptor partial agonist d-cycloserine does not enhance motor learning. |
2016 |
J. Psychopharmacol. (Oxford) |
pmid:27436230
|
Liraz-Zaltsman S et al. |
Neuroinflammation-Induced Memory Deficits Are Amenable to Treatment with D-Cycloserine. |
2016 |
J. Mol. Neurosci. |
pmid:27421842
|
Storch EA et al. |
Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial. |
2016 |
JAMA Psychiatry |
pmid:27367832
|
Otto MW et al. |
RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER. |
2016 |
Depress Anxiety |
pmid:27315514
|
Goff D |
The Therapeutic Role of d-Cycloserine in Schizophrenia. |
2016 |
Adv. Pharmacol. |
pmid:27288073
|
Otto MW et al. |
Examining the efficacy of d-cycloserine to augment therapeutic learning in depression. |
2016 |
Contemp Clin Trials |
pmid:27094721
|
Yu X et al. |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates. |
2016 |
Int. J. Tuberc. Lung Dis. |
pmid:27046713
|
Smits JA et al. |
Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial. |
2016 |
Contemp Clin Trials |
pmid:27015966
|
Fang A and Wilhelm S |
Antidepressant use with d-Cycloserine may block fear extinction. |
2016 |
Evid Based Ment Health |
pmid:26792833
|
Qiu W et al. |
d-Alanine metabolism is essential for growth and biofilm formation of Streptococcus mutans. |
2016 |
Mol Oral Microbiol |
pmid:26526529
|